Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and Pfizer (PFE)

Tipranks - Tipranks - Wed Apr 15, 9:26AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Avita Medical (RCEL) and Pfizer (PFE).

Claim 30% Off TipRanks

Avita Medical (RCEL)

Lake Street analyst Frank Takkinen maintained a Hold rating on Avita Medical today and set a price target of $3.50. The company’s shares closed last Tuesday at $5.20.

According to TipRanks.com, Takkinen is ranked 0 out of 5 stars with an average return of -4.3% and a 35.9% success rate. Takkinen covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., Adagio Medical Holdings, and TriSalus Life Sciences. ;'>

Currently, the analyst consensus on Avita Medical is a Moderate Buy with an average price target of $6.33, which is a 29.4% upside from current levels. In a report issued on April 2, TipRanks – PerPlexity also upgraded the stock to Hold with a $3.50 price target.

See today’s best-performing stocks on TipRanks >>

Pfizer (PFE)

Scotiabank analyst Louise Chen maintained a Buy rating on Pfizer today and set a price target of $30.00. The company’s shares closed last Tuesday at $27.24.

According to TipRanks.com, Chen is a 4-star analyst with an average return of 3.1% and a 47.4% success rate. Chen covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Bristol-Myers Squibb, and Teva Pharmaceutical. ;'>

Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $29.12, which is a 7.1% upside from current levels. In a report issued on April 12, Guggenheim also reiterated a Buy rating on the stock with a $36.00 price target.

Read More on RCEL:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).